Lyell Immunopharma Inc Ordinary Shares
North American company
Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors.
Latest LYEL News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News